http://www.neurology.org/cgi/content/abstract/57/10/1885
Neurology 2001;57:1885-1888
Nancy L. Sicotte, MD and Rhonda
R. Voskuhl, MD
From the Division of Brain Mapping
(Dr. Sicotte), Department of Neurology (Drs. Sicotte and Voskuhl), UCLA
School of Medicine, Los Angeles, CA.
Brief Communications
Therapies aimed at inhibiting tumor
necrosis factor (TNF), a proinflammatory cytokine implicated in autoimmune
disease are effective, especially for rheumatoid arthritis.
We report a patient with new onset
MS closely associated with the initiation of anti-TNF therapy for juvenile
rheumatoid arthritis.
It is possible that the inhibition
of TNF triggered MS in this individual.
© 2001 American Academy of Neurology